Related Experiment Videos
Targeted perinatal drug screening in a rural population
T A O'Connor1, H H Bondurant, J Siddiqui
1Division of Neonatal-Perinatal Medicine, Children's Hospital, University of Missouri, Columbia 65212, USA.
Insights
Risk factor-based drug screening effectively identifies infant drug exposure in rural areas. Meconium testing is superior to urine testing for detecting illicit substances like marijuana and cocaine.
Area of Science:
- Perinatal care
- Neonatal drug screening
- Public health
Background:
- Rural perinatal populations often have low reported substance abuse rates, posing challenges for effective screening.
- Traditional universal screening may not be resource-efficient in low-prevalence settings.
Purpose of the Study:
- To evaluate the efficacy of a risk factor-based drug screening program versus universal screening in a rural newborn population.
- To compare the detection rates of meconium and infant urine drug screening.
Main Methods:
- A risk factor-based meconium and infant urine drug screening program was compared to universal meconium screening.
- The study included 462 deliveries over a 3-month period at a university-based children's hospital.
- Drug testing criteria were applied to identify eligible newborns for screening.
Main Results:
- Eighteen percent of deliveries met criteria for drug testing.
- Of those tested, 12.9% (11/85) tested positive for marijuana or cocaine, a 2.4% detection rate overall.
- Meconium analysis detected marijuana exposure in three cases where urine analysis was negative, indicating meconium's higher sensitivity.
Conclusions:
- Risk factor-based meconium drug screening is effective in identifying illicit drug exposure in rural, low-prevalence perinatal populations.
- Meconium sampling demonstrates a higher likelihood of detecting infant drug exposure compared to urine sampling.
Abstract:
The objectives of this study was to evaluate the efficacy of a risk factor-based drug screening program in a rural perinatal population with a low prevalence of substance abuse. The study was done at a university-based children's hospital in central Missouri. A risk factor-based meconium and infant urine drug screening program was compared to a universal meconium screening program in a newborn population over a 3 month period. Eighteen percent of the 462 deliveries met criteria for drug testing. Of those tested, 11/85 (12.9%) tested positive for marijuana (n = 8) or cocaine (n = 3), representing a detection rate of 2.4% of the total population. This compares well to the 2.6% detected in the universal testing protocol. In three patients, meconium analysis detected marijuana exposure, while urine analysis revealed no detectable drug. Risk factor-based meconium drug screening can identify most infants exposed to illicit drugs in rural perinatal populations with low baseline substance abuse rates. Meconium sampling is more likely than urine sampling to identify exposed infants.